A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Cytokinetics Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 365,967 shares of CYTK stock, worth $19.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
365,967
Previous 35,967 917.51%
Holding current value
$19.3 Million
Previous $3 Million 754.41%
% of portfolio
0.04%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$63.75 - $108.06 $21 Million - $35.7 Million
330,000 Added 917.51%
365,967 $25.7 Million
Q4 2023

Feb 13, 2024

BUY
$26.88 - $83.49 $966,792 - $3 Million
35,967 New
35,967 $3 Million
Q4 2022

Feb 13, 2023

BUY
$35.77 - $51.11 $2.64 Million - $3.77 Million
73,667 New
73,667 $3.38 Million
Q4 2021

Feb 11, 2022

SELL
$34.35 - $46.38 $11.6 Million - $15.7 Million
-338,367 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$18.54 - $35.74 $4.96 Million - $9.56 Million
267,600 Added 378.14%
338,367 $12.1 Million
Q2 2021

Aug 13, 2021

BUY
$19.79 - $26.99 $1.4 Million - $1.91 Million
70,767 New
70,767 $1.4 Million
Q3 2020

Nov 13, 2020

SELL
$20.58 - $28.96 $1.46 Million - $2.06 Million
-71,067 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$11.15 - $24.64 $792,397 - $1.75 Million
71,067 New
71,067 $1.68 Million
Q1 2020

May 14, 2020

SELL
$8.75 - $16.3 $1.35 Million - $2.51 Million
-153,767 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$7.95 - $11.84 $663,562 - $988,249
83,467 Added 118.73%
153,767 $1.63 Million
Q3 2019

Nov 13, 2019

SELL
$10.82 - $14.25 $3.22 Million - $4.25 Million
-298,000 Reduced 80.91%
70,300 $800,000
Q2 2019

Aug 12, 2019

BUY
$7.95 - $11.25 $739,350 - $1.05 Million
93,000 Added 33.78%
368,300 $4.14 Million
Q1 2019

May 14, 2019

BUY
$5.95 - $10.19 $1.52 Million - $2.61 Million
256,100 Added 1333.85%
275,300 $2.23 Million
Q4 2018

Feb 13, 2019

BUY
$5.91 - $9.29 $113,472 - $178,367
19,200 New
19,200 $121,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.98B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.